{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Babesia divergens", "MMV006913", "in vitro", "large-scale screening", "malaria box"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34885700", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "16"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "24"}], "Language": ["eng"], "ELocationID": ["7118", "10.3390/molecules26237118"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "23", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "24"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of <i>Babesia divergens</i>, a Blood-Borne Parasite of Veterinary and Zoonotic Importance.", "Abstract": {"AbstractText": ["Babesiosis is an infectious disease with an empty drug pipeline. A search inside chemical libraries for novel potent antibabesial candidates may help fill such an empty drug pipeline. A total of 400 compounds (200 drug-like and 200 probe-like) from the Malaria Box were evaluated in the current study against the in vitro growth of <i>Babesia divergens</i> (<i>B. divergens</i>), a parasite of veterinary and zoonotic importance. Novel and more effective anti-<i>B. divergens</i> drugs than the traditionally used ones were identified. Seven compounds (four drug-like and three probe-like) revealed a highly inhibitory effect against the in vitro growth of <i>B. divergens</i>, with IC<sub>50</sub>s \u2264 10 nanomolar. Among these hits, MMV006913 exhibited an IC<sub>50</sub> value of 1 nM IC<sub>50</sub> and the highest selectivity index of 32,000. The atom pair fingerprint (APfp) analysis revealed that MMV006913 and MMV019124 showed maximum structural similarity (MSS) with atovaquone and diminazene aceturate (DA), and with DA and imidocarb dipropionate (ID), respectively. MMV665807 and MMV665850 showed MMS with each other and with ID. Of note, a high concentration (0.75 IC<sub>50</sub>) of MMV006913 caused additive inhibition of <i>B. divergens</i> growth when combined with DA at 0.75 or 0.50 IC<sub>50</sub>. The Medicines for Malaria Venture box is a treasure trove of anti-<i>B. divergens</i> candidates according to the obtained results."]}, "AuthorList": [{"Identifier": ["0000-0002-5250-6172"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro 080-8555, Hokkaido, Japan."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Dakahlia, Egypt."}], "LastName": "Rizk", "ForeName": "Mohamed Abdo", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro 080-8555, Hokkaido, Japan."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Dakahlia, Egypt."}], "LastName": "El-Sayed", "ForeName": "Shimaa Abd El-Salam", "Initials": "SAE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Mansoura University, Mansoura 35516, Dakahlia, Egypt."}], "LastName": "Alkhoudary", "ForeName": "Mahmoud S", "Initials": "MS"}, {"Identifier": ["0000-0002-8156-2069"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}], "LastName": "Alsharif", "ForeName": "Khalaf F", "Initials": "KF"}, {"Identifier": ["0000-0002-4341-2713"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Abdel-Daim", "ForeName": "Mohamed M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-Cho, Obihiro 080-8555, Hokkaido, Japan."}], "LastName": "Igarashi", "ForeName": "Ikuo", "Initials": "I"}], "GrantList": [{"GrantID": "not available", "Agency": "Medicines for Malaria Venture Malaria Box", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiprotozoal Agents"}, {"RegistryNumber": "8USS3K0VDH", "NameOfSubstance": "Imidocarb"}, {"RegistryNumber": "JI8SAD85NO", "NameOfSubstance": "diminazene aceturate"}, {"RegistryNumber": "Y5G36EEA5Z", "NameOfSubstance": "Diminazene"}, {"RegistryNumber": "Y883P1Z2LT", "NameOfSubstance": "Atovaquone"}, {"RegistryNumber": "ZSM1M03SHC", "NameOfSubstance": "imidocarb dipropionate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiprotozoal Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Atovaquone"}, {"QualifierName": ["drug effects", "pathogenicity"], "DescriptorName": "Babesia"}, {"QualifierName": ["drug therapy", "parasitology"], "DescriptorName": "Babesiosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood-Borne Pathogens"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Diminazene"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Imidocarb"}, {"QualifierName": ["drug therapy", "epidemiology", "parasitology"], "DescriptorName": "Malaria"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Suarez C.E., Alzan H.F., Silva M.G., Rathinasamy V., Poole W.A., Cooke B.M. Unravelling the cellular and molecular pathogenesis of bovine babesiosis: Is the sky the limit? Int. J. Parasitol. 2019;49:183\u2013197. doi: 10.1016/j.ijpara.2018.11.002.", "ArticleIdList": ["10.1016/j.ijpara.2018.11.002", "PMC6988112", "30690089"]}, {"Citation": "Rizk M.A., El-Sayed S.A.E., El-Khodery S., Yokoyama N., Igarashi I. Discovering the in vitro potent inhibitors against Babesia and Theileria parasites by repurposing the Malaria Box: A review. Vet. Parasitol. 2019;274:108895. doi: 10.1016/j.vetpar.2019.07.003.", "ArticleIdList": ["10.1016/j.vetpar.2019.07.003", "31494399"]}, {"Citation": "Rizk M.A., AbouLaila M., El-Sayed S.A.E., Guswanto A., Yokoyama N., Igarashi I. Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance. Infect. Drug Resist. 2018;11:1605\u20131615. doi: 10.2147/IDR.S159519.", "ArticleIdList": ["10.2147/IDR.S159519", "PMC6166754", "30310296"]}, {"Citation": "Rizk M.A., El-Sayed S.A.E., Nassif M., Mosqueda J., Xuan X., Igarashi I. Assay methods for in vitro and in vivo anti-Babesia drug efficacy testing: Current progress, outlook, and challenges. Vet. Parasitol. 2020;279:109013. doi: 10.1016/j.vetpar.2019.109013.", "ArticleIdList": ["10.1016/j.vetpar.2019.109013", "32070899"]}, {"Citation": "Zintl A., Mulcahy G., Skerrett H.E., Taylor S.M., Gray J.S. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin. Microbiol Rev. 2003;16:622\u2013636. doi: 10.1128/CMR.16.4.622-636.2003.", "ArticleIdList": ["10.1128/CMR.16.4.622-636.2003", "PMC207107", "14557289"]}, {"Citation": "Van Voorhis W.C., Adams J.H., Adelfio R., Ahyong V., Akabas M.H., Alano P., Alday A., Aleman Resto Y., Alsibaee A., Alzualde A., et al. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. PLoS Pathog. 2016;12:e1005763. doi: 10.1371/journal.ppat.1005763.", "ArticleIdList": ["10.1371/journal.ppat.1005763", "PMC4965013", "27467575"]}, {"Citation": "Bennett T.N., Paguio M., Gligorijevic B., Seudieu C., Kosar A.D., Davidson E., Roepe P.D. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob. Agents Chemother. 2004;48:1807\u20131810. doi: 10.1128/AAC.48.5.1807-1810.2004.", "ArticleIdList": ["10.1128/AAC.48.5.1807-1810.2004", "PMC400551", "15105139"]}, {"Citation": "Spangenberg T., Burrows J.N., Kowalczyk P., McDonald S., Wells T.N., Willis P. The open access malaria box: A drug discovery catalyst for neglected diseases. PLoS ONE. 2013;8:e62906. doi: 10.1371/journal.pone.0062906.", "ArticleIdList": ["10.1371/journal.pone.0062906", "PMC3684613", "23798988"]}, {"Citation": "Paul A.S., Moreira C.K., Elsworth B., Allred D.R., Duraisingh M.T. Extensive Shared Chemosensitivity between Malaria and Babesiosis Blood-Stage Parasites. Antimicrob. Agents Chemother. 2016;60:5059\u20135063. doi: 10.1128/AAC.00928-16.", "ArticleIdList": ["10.1128/AAC.00928-16", "PMC4958166", "27246780"]}, {"Citation": "Elabbadi N., Ancelin M.L., Vial H.J. Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique. Antimicrob. Agents Chemother. 1992;36:50\u201355. doi: 10.1128/AAC.36.1.50.", "ArticleIdList": ["10.1128/AAC.36.1.50", "PMC189224", "1590699"]}, {"Citation": "Chulay J.D., Haynes J.D., Diggs C.L. Plasmodium falciparum: Assessment of in vitro growth by [3H]hypoxanthine incorporation. Exp. Parasitol. 1983;55:138\u2013146. doi: 10.1016/0014-4894(83)90007-3.", "ArticleIdList": ["10.1016/0014-4894(83)90007-3", "6337059"]}, {"Citation": "Geary T.G., Divo A.A., Jensen J.B. An in vitro assay system for the identification of potential antimalarial drugs. J. Parasitol. 1983;69:577\u2013583. doi: 10.2307/3281373.", "ArticleIdList": ["10.2307/3281373", "6355423"]}, {"Citation": "Sherman I.W. Transport of amino acids and nucleic acid precursors in malarial parasites. Bull. World Health Organ. 1977;55:211\u2013225.", "ArticleIdList": ["PMC2366738", "338180"]}, {"Citation": "Irvin A.D., Young E.R. Further studies on the uptake of tritiated nucleic acid precursors by Babesia spp. of cattle and mice. Int. J. Parasitol. 1979;9:109\u2013114. doi: 10.1016/0020-7519(79)90099-7.", "ArticleIdList": ["10.1016/0020-7519(79)90099-7", "631976"]}, {"Citation": "Hassan H.F. Purine-metabolising enzymes in Babesia divergens. Zeit. Parasitenkund. 1987;73:121\u2013125.", "ArticleIdList": ["3033631"]}, {"Citation": "Lobo C.A. Babesia divergens and Plasmodium falciparum use common receptors, glycophorins A and B, to invade the human red blood cell. Infect. Immun. 2005;73:649\u2013651. doi: 10.1128/IAI.73.1.649-651.2005.", "ArticleIdList": ["10.1128/IAI.73.1.649-651.2005", "PMC538995", "15618210"]}, {"Citation": "Bork S., Yokoyama N., Ikehara Y., Kumar S., Sugimoto C., Igarashi I. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob. Agents Chemother. 2004;48:236\u2013241. doi: 10.1128/AAC.48.1.236-241.2004.", "ArticleIdList": ["10.1128/AAC.48.1.236-241.2004", "PMC310193", "14693545"]}, {"Citation": "Baum J., Chen L., Healer J., Lopaticki S., Boyle M., Triglia T., Ehlgen F., Ralph S.A., Beeson J.G., Cowman A.F. Reticulocyte-binding protein homologue 5-an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int J. Parasitol. 2009;39:371\u2013380. doi: 10.1016/j.ijpara.2008.10.006.", "ArticleIdList": ["10.1016/j.ijpara.2008.10.006", "19000690"]}, {"Citation": "Boyle M.J., Richards J.S., Gilson P.R., Chai W., Beeson J.G. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood. 2010;115:4559\u20134568. doi: 10.1182/blood-2009-09-243725.", "ArticleIdList": ["10.1182/blood-2009-09-243725", "20220119"]}, {"Citation": "Kobayashi K., Kato K., Sugi T., Takemae H., Pandey K., Gong H., Tohya Y., Akashi H. Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface. J. Biol. Chem. 2010;285:1716\u20131725. doi: 10.1074/jbc.M109.021576.", "ArticleIdList": ["10.1074/jbc.M109.021576", "PMC2804329", "19940142"]}, {"Citation": "Kobayashi K., Takano R., Takemae H., Sugi T., Ishiwa A., Gong H., Recuenco F.C., Iwanaga T., Horimoto T., Akashi H., et al. Analyses of interactions between heparin and the apical surface proteins of Plasmodium falciparum. Sci. Rep. 2013;3:3178. doi: 10.1038/srep03178.", "ArticleIdList": ["10.1038/srep03178", "PMC3822384", "24212193"]}, {"Citation": "Boyom F.F., Fokou P.V., Tchokouaha L.R., Spangenberg T., Mfopa A.N., Kouipou R.M., Mbouna C.J., Donfack V.F., Zollo P.H. Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica. Antimicrob. Agents Chemother. 2014;58:5848\u20135854. doi: 10.1128/AAC.02541-14.", "ArticleIdList": ["10.1128/AAC.02541-14", "PMC4187973", "25049259"]}, {"Citation": "Ingram-Sieber K., Cowan N., Panic G., Vargas M., Mansour N.R., Bickle Q.D., Wells T.N., Spangenberg T., Keiser J. Orally active antischistosomal early leads identified from the open access malaria box. PLoS Negl. Trop Dis. 2014;8:e2610. doi: 10.1371/journal.pntd.0002610.", "ArticleIdList": ["10.1371/journal.pntd.0002610", "PMC3886923", "24416463"]}, {"Citation": "Bessoff K., Spangenberg T., Foderaro J.E., Jumani R.S., Ward G.E., Huston C.D. Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box. Antimicrob. Agents Chemother. 2014;58:2731\u20132739. doi: 10.1128/AAC.02641-13.", "ArticleIdList": ["10.1128/AAC.02641-13", "PMC3993250", "24566188"]}, {"Citation": "Rizk M.A., El-Sayed S.A., Terkawi M.A., Youssef M.A., El Said el Sel S., Elsayed G., El-Khodery S., El-Ashker M., Elsify A., Omar M., et al. Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites. PLoS ONE. 2015;10:e0125276. doi: 10.1371/journal.pone.0125276.", "ArticleIdList": ["10.1371/journal.pone.0125276", "PMC4411034", "25915529"]}, {"Citation": "Rizk M.A., El-Sayed S.A., AbouLaila M., Tuvshintulga B., Yokoyama N., Igarashi I. Large-scale drug screening against Babesia divergens parasite using a fluorescence-based high-throughput screening assay. Vet. Parasitol. 2016;227:93\u201397. doi: 10.1016/j.vetpar.2016.07.032.", "ArticleIdList": ["10.1016/j.vetpar.2016.07.032", "27523944"]}, {"Citation": "Lau A.O., Pedroni M.J., Bhanot P. Target specific-trisubstituted pyrrole inhibits Babesia bovis erythrocytic growth. Exp. Parasitol. 2013;133:365\u2013368. doi: 10.1016/j.exppara.2012.12.013.", "ArticleIdList": ["10.1016/j.exppara.2012.12.013", "23274642"]}, {"Citation": "El-Sayed S.A.E., Rizk M.A., Terkawi M.A., Yokoyama N., Igarashi I. Molecular identification and antigenic characterization of Babesia divergens Erythrocyte Binding Protein (BdEBP) as a potential vaccine candidate. Parasitol. Int. 2017;66:721\u2013726. doi: 10.1016/j.parint.2017.07.004.", "ArticleIdList": ["10.1016/j.parint.2017.07.004", "28743470"]}, {"Citation": "Rizk M.A., El-Sayed S.A.E., AbouLaila M., Yokoyama N., Igarashi I. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites. Exp. Parasitol. 2017;179:43\u201348. doi: 10.1016/j.exppara.2017.06.003.", "ArticleIdList": ["10.1016/j.exppara.2017.06.003", "28655583"]}, {"Citation": "O\u2019Boyle N.M., Sayle R.A. Comparing structural fingerprints using a literature based similarity benchmark. J. Cheminformatics. 2016;8:2206\u20132219. doi: 10.1186/s13321-016-0148-0.", "ArticleIdList": ["10.1186/s13321-016-0148-0", "PMC4932683", "27382417"]}, {"Citation": "Backman T.W., Cao Y., Girke T. ChemMine tools: An online service for analyzing and clustering small molecules. Nucleic Acids Res. 2011;39:W486\u2013W491. doi: 10.1093/nar/gkr320.", "ArticleIdList": ["10.1093/nar/gkr320", "PMC3125754", "21576229"]}, {"Citation": "Cao Y., Charisi A., Cheng L.C., Jiang T., Girke T. ChemmineR: A compound mining framework for R. Bioinformatics. 2008;24:1733\u20131744. doi: 10.1093/bioinformatics/btn307.", "ArticleIdList": ["10.1093/bioinformatics/btn307", "PMC2638865", "18596077"]}, {"Citation": "El-Sayed S.A.E., Rizk M.A., Yokoyama N., Igarashi I. Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites. Parasit. Vectors. 2019;12:37. doi: 10.1186/s13071-019-3296-z.", "ArticleIdList": ["10.1186/s13071-019-3296-z", "PMC6335684", "30651142"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "29"}, {"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2021", "Month": "11", "Day": "23"}, {"Year": "2021", "Month": "12", "Day": "10", "Hour": "1", "Minute": "7"}, {"Year": "2021", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["34885700", "PMC8658764", "10.3390/molecules26237118", "molecules26237118"]}}], "PubmedBookArticle": []}